Subscribe to
this category


A total of 39 posts are filed under Strategy
Aselage to Retire from Retrophin; Retrophin, Albireo appoint new CMOs
Rare Daily Staff Rare disease drug company Retrophin said its CEO Stephen Aselage will retire and that the company’s board of directors… Continue Reading
Abeona, Syntimmue Strengthen Leadership Teams
Rare Daily Staff Rare disease drug developers Abeona Therapeutics and Syntimmune both announced executive appointments to strengthen their… Continue Reading
CVC Capital Partners Buys Controlling Stake in Recordati for $3.5 Billion
Rare Daily Staff A consortium of funds led by CVC Capital Partners has agreed to buy a majority interest in drugmaker Recordati for $3.5… Continue Reading
Sanofi Genzyme Creates Challenge to Find Digital Technologies to Speed Rare Disease Diagnoses
Rare Daily Staff Sanofi Genzyme has issued a call for submissions for its Rare Innovation Challenge, an effort to find innovative digital… Continue Reading
MHRA Grants MeiraGTx License for London Manufacturing Facility
Rare Daily Staff MeiraGTx The U.K.’s Medicines and Healthcare products Regulatory Agency granted MeiraGTx a Manufacturer’s Authorization… Continue Reading
Express Scripts Program Designed to Meet Needs of Payers, Not Patients
At the end of May, the pharmacy benefits manager Express Scripts announced a new program it said was aimed at “reducing the burden on… Continue Reading
Inozyme Pharma Offers No-Cost Genetic Testing for Rare Calcification Disorders
Rare Daily Staff Inozyme Pharma has introduced a no-cost, third-party genetic testing program designed to improve detection and… Continue Reading
1 2 3 6

Follow us on Twitter